← Back to Search

Diagnostic Imaging

XFM-Guided Catheterization for Congenital Heart Defects

N/A

Waitlist Available

Led By Joshua Kanter, MD

Research Sponsored by Joshua Kanter

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of each catheterization procedure through study completion,up to 8 years.

Awards & highlights

Study Summary

This trial will determine if using x-rays fused with MR images can help guide catheter tools during cardiac procedures.

Who is the study for?

This trial is open to children and adults of any age who need a heart catheterization for diagnostic or treatment purposes. It's not suitable for those with unstable heart conditions, pregnant or nursing women (unless they can discard breast milk for 24 hours), or anyone with certain metal implants that are unsafe in MRI machines.Check my eligibility

What is being tested?

The study is testing the use of XFM, which combines x-ray and MRI imaging, to guide catheters during heart procedures. The goal is to see if this method improves the accuracy and safety of these medical interventions.See study design

What are the potential side effects?

Since XFM guidance is an imaging technique rather than a drug, it doesn't have typical side effects. However, there may be risks associated with exposure to radiation from x-rays and potential issues related to being in an MRI machine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of each catheterization procedure through study completion,up to 8 years.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of each catheterization procedure through study completion,up to 8 years.

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of each catheterization procedure through study completion,up to 8 years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Radiation exposure measurement

Secondary outcome measures

Contrast volume measurement

Fluoroscopy

Procedure time measurement

Trial Design

1Treatment groups

Experimental Treatment

Group I: XFM guidanceExperimental Treatment1 Intervention

X-ray fused cardiac MRI images used for guidance tool to perform cardiac catheterization procedure

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

XFM guidance

2013

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Joshua KanterLead Sponsor

1 Previous Clinical Trials

50 Total Patients Enrolled

Joshua Kanter, MDPrincipal InvestigatorChildren's National Hospital System

2 Previous Clinical Trials

132 Total Patients Enrolled

Media Library

XFM guidance (Diagnostic Imaging) Clinical Trial Eligibility Overview. Trial Name: NCT02737579 — N/A

Congenital Heart Defects Research Study Groups: XFM guidance

Congenital Heart Defects Clinical Trial 2023: XFM guidance Highlights & Side Effects. Trial Name: NCT02737579 — N/A

XFM guidance (Diagnostic Imaging) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02737579 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies in this medical experiment that participants can fill?

"As per the clinicaltrials.gov database, this medical trial is no longer enrolling participants at present time. The research was initially posted on July 23rd 2013 and underwent its last update on March 28th 2022. Nevertheless, there are still 99 other trials actively seeking to add patients to their studies as we speak."

Answered by AI

Recent research and studies

CirculationJournal

X-ray Fused with Magnetic Resonance Imaging (XFM) to Target Endomyocardial Injections

de Silva, Ranil, Luis F. Gutiérrez, Amish N. Raval, Elliot R. McVeigh, Cengizhan Ozturk, and Robert J. Lederman. 2006. “X-ray Fused with Magnetic Resonance Imaging (XFM) to Target Endomyocardial Injections”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.105.598524.

CirculationJournal

Γ-h2ax Foci as a Biomarker for Patient X-ray Exposure in Pediatric Cardiac Catheterization

Beels, Laurence, Klaus Bacher, Daniël De Wolf, Joke Werbrouck, and Hubert Thierens. 2009. “Γ-h2ax Foci as a Biomarker for Patient X-ray Exposure in Pediatric Cardiac Catheterization”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/circulationaha.109.880385.

European Journal of RadiologyJournal

Tolerance Data of Gd-dtpa: A Review

Niendorf, H.P, J.C Dinger, J Haustein, I Cornelius, A Alhassan, and W Clauß. 1991. “Tolerance Data of Gd-dtpa: A Review”. European Journal of Radiology. Elsevier BV. doi:10.1016/0720-048x(91)90049-2.

Catheterization and Cardiovascular InterventionsJournal